PSORIATIC ARTHRITIS

This study tests whether bimekizumab works better than risankizumab for adults with active psoriatic arthritis (PsA), a condition causing joint pain, swelling, and skin plaques. About 684 participants who have not responded well to standard treatments will receive one of the two …

This study looks at the long-term safety and effectiveness of a drug called bimekizumab for adults with active psoriatic arthritis, a condition causing joint pain and skin patches. Over 1,100 participants who completed earlier studies will receive the drug as an injection and be …

This study tests a daily pill called deucravacitinib against a placebo in 670 adults with active psoriatic arthritis who have never taken biologic drugs. The goal is to see if the drug reduces joint swelling and pain after 16 weeks, and to check its long-term safety. Participants…

This study looks at the long-term safety and effectiveness of tildrakizumab for people with psoriatic arthritis, a condition causing joint pain and swelling. About 529 adults who completed a prior study will continue receiving the drug. The main goals are to track side effects an…

This study looked at how well a metal plate (A.L.P.S. Proximal Humerus Plating System) works for fixing broken upper arm bones. It included 135 adults who needed surgery for a fresh fracture. The main goal was to see how many people needed another surgery within a year due to pro…

This study watches for side effects in 881 people with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or psoriasis who receive Remsima under the skin. It aims to see how safe the injection is over time. Participants must have active disease that didn't respond…

This study aims to find a faster way to detect psoriatic arthritis (PsA) in people who have psoriasis but haven't been diagnosed with PsA yet. Researchers are sending screening questionnaires directly to 18,000 adults with psoriasis, bypassing the doctor's office, to see if this …

This study tests whether a dedicated care coordinator can help people with psoriasis or psoriatic arthritis lower their risk of heart disease. About 520 adults aged 40-75 who are not already on cholesterol medication will receive support to manage risk factors like high cholester…

This study tests an online program designed to help people with inflammatory arthritis stay employed. About 528 adults with conditions like rheumatoid arthritis or lupus will either use the program or receive standard care and printed materials. The program includes eLearning and…

This study looks at how the drug bimekizumab affects gene activity in people with moderate to severe plaque psoriasis, with or without psoriatic arthritis. Researchers will take small skin samples to measure changes in gene expression over 48 weeks. The goal is to better understa…

This study looks at whether giving people with inflammatory arthritis extra help—like a list of community resources, a community specialist, or a nurse navigator—can reduce missed doctor visits. About 100 adults with conditions like rheumatoid arthritis or lupus who have missed a…

This study planned to follow women with rare autoimmune diseases (like lupus or arthritis) through pregnancy to learn about complications and improve care. It was withdrawn before any participants enrolled, so no results are available. The goal was to gather information to help d…

This study looks at whether a smartphone app can help people with psoriatic arthritis manage their condition with fewer in-person doctor visits. About 278 adults who own a smartphone and take certain arthritis medications will use the app to report symptoms. Researchers will trac…

This study looks at whether healthcare professionals in Saudi Arabia are aware of and follow safety measures for the drug Leflunomide (Arava), used for rheumatoid and psoriatic arthritis. Researchers will survey about 3,500 doctors and pharmacists to see if they received and read…

This study is a registry that will follow up to 5,000 people with psoriatic arthritis or spondyloarthritis to see how well approved treatments work in everyday life. Researchers will track safety, disease patterns, and current treatment practices. Participants are already being e…